Evidence map›Paper›PMID 28883763›Full record

ArticleReports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology

Cyberknife stereotactic radiosurgery and denosumab for giant cell tumour of the skull base: Case report.

Cuauhtemoc de la Peña, Jorge H Guajardo, Maria F Gonzalez, Miguel A Hinojosa, Erick Cardona

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cuauhtemoc de la PeñaDepartment of Radiosurgery, Neuro-Oncology Unit, Hospital de Alta Especialidad Chistrus Muguerza, Monterrey, Nuevo León, Mexico.
Jorge H GuajardoDepartment of Neurosurgery, Neuro-Oncology Unit, Hospital de Alta Especialidad Chistrus Muguerza, Monterrey, Nuevo León, Mexico.
Maria F GonzalezDepartment of Neuro-oncology, Neuro-Oncology Unit, Hospital de Alta Especialidad Chistrus Muguerza, Monterrey, Nuevo León, Mexico.
Miguel A HinojosaDepartment of Physics, Neuro-Oncology Unit, Hospital de Alta Especialidad Chistrus Muguerza, Monterrey, Nuevo León, Mexico.
Erick CardonaDepartment of Physics, Neuro-Oncology Unit, Hospital de Alta Especialidad Chistrus Muguerza, Monterrey, Nuevo León, Mexico.
Hospital Regional de Alta Especialidad del Bajío · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Giant cell tumours (GCT) of the skull is a rare entity with only small number of cases reported in literature and optimal treatment is yet to be determined. These tumours have shown high recurrence rates after incomplete surgery, usually occurring during the first year. Even with new surgical techniques a complete resection in skull base tumours is not always possible without functional compromise. Therefore, adjuvant therapy is essential to enhance local control and quality of life. We report a rare case of a 34-year-old male with giant cell tumour (GCT) of the skull base involving the petrous bone, clivus and sphenoid body. The patient received Cyberknife stereotactic radiosurgery (CK SRS) and denosumab after surgery. This combined therapy allowed local control and tumour reduction with secondary neurological improvement during a 4-year follow up.

Indexed as

CyberknifeDenosumabGiant cell tumourSkull baseStereotactic radiosurgery

Identifiers

PMID28883763
PMCPMC5581862
OpenAlexW2751275226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.